As 2026 begins, the global hepatology community is closely monitoring a wave of breakthrough data from Phase II and III trials that aim to permanently correct the ATP7B genetic mutation. Regulatory authorities in the European Union and the United States have recently signaled a willingness to accept biomarker-driven endpoints, such as long-term reduction in non-ceruloplasmin bound copper, to...

The Anti-Radiation Drugs Market is gaining strong global momentum due to the increasing use of radiation therapy in cancer treatment and growing concerns regarding radiation exposure from medical and nuclear sources. Anti-radiation drugs play a critical role in protecting healthy tissues from radiation damage, reducing toxicity levels, and improving treatment outcomes for patients undergoing...